STOCK TITAN

Health Catalyst Stock Price, News & Analysis

HCAT Nasdaq

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.

Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.

Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.

Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.04%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.49%
Tags
partnership
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.49%
Tags
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) will announce its first quarter 2023 operating results on May 9, 2023, after market close. The company will hold a conference call at 5 p.m. E.T. to discuss these results. Interested participants can join via phone at 800-225-9448 for U.S. callers or 203-518-9708 for international callers, citing conference ID HCAT Q123. A live audio webcast will also be available at Health Catalyst's Investor Relations site. The call will be accessible for replay for 90 days post-event. Health Catalyst provides data and analytics technology to healthcare organizations, utilizing a platform powered by over 100 million patient records. Their mission is to enable data-informed healthcare improvements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.11%
Tags
conferences earnings
-
Rhea-AI Summary

Health Catalyst (NASDAQ: HCAT) announced a multi-year partnership with Contexture, the largest health information exchange in the west, on April 4, 2023. This collaboration aims to unify Contexture's technology platforms into a single stack to enhance efficiency and data migration across its network. Contexture's CEO, Melissa Kotrys, emphasized the importance of real-time data access for improving care outcomes. The partnership will leverage Health Catalyst's comprehensive solutions to support performance improvement activities and ensure timely access to data. The move is expected to strengthen healthcare decision-making across participating organizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
partnership
-
Rhea-AI Summary

Contexture, the largest health information organization in the western U.S., has announced plans to transition to a unified technology platform for its health information exchange (HIE) services across Arizona and Colorado. The upgrade, set to begin in 2023 and complete by 2025, will enhance data exchange capabilities for approximately 28 million patients. Key benefits include improved electronic health record interoperability, enhanced security, greater flexibility, and a better user experience. This initiative marks an expansion of Contexture's partnership with Health Catalyst, a leader in healthcare data analytics, aimed at improving patient care quality and system efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.31%
Tags
none
Rhea-AI Summary

Health Catalyst, a leading provider of data analytics technology, has partnered with GI Quality Improvement Consortium (GIQuIC) to enhance the nation's only gastroenterology-focused clinical registry. This collaboration will leverage Health Catalyst's ARMUS solution to streamline data entry and improve reporting for GIQuIC's registry participants. By early 2024, GIQuIC aims to transition its operations for colonoscopy and EGD procedures and expand data collection on various endoscopic procedures and disease states. This partnership is expected to enhance healthcare quality through improved data management and analytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
none

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $2.39 as of January 1, 2026.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 169.0M.
Health Catalyst

Nasdaq:HCAT

HCAT Rankings

HCAT Stock Data

169.05M
67.45M
3.52%
79.72%
7.46%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
SOUTH JORDAN